Epigenetic Biomarker
A cancer biomarker is a biological marker which indicates the presence of cancer in the body. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers are used for diagnosis, prognosis, and epidemiology of cancer.
Because they are expressed against a person's genetic background and environmental exposure, and epigenetic events occur early in cancer development, Epigenetic biomarkers are more advantageous over other types of biomarkers.
Epigenetic biomarkers potentially have numerous clinical applications in cancer intervention and treatment and significant implications for public health.
Types of epigenetic biomarkers:
- DNA methylation, circulating or noncirculating
- MicroRNA and other noncoding RNA
- Protein markers
For e.g., DNA methylation is one of the major epigenetic mechanisms and it is a genetic feature better reflecting disease development and, consequently, has the potential to become a more conclusive biomarker for detection and diagnosis of different diseases.
Related Conference of Epigenetic Biomarker
November 24-25, 2025
16th International Conference on Cancer Stem Cell & Oncology Research
Barcelona, Spain
April 13-14, 2026
23rd International Conference on Breast Pathology and Cancer Diagnosis
Tokyo, Japan
Epigenetic Biomarker Conference Speakers
Recommended Sessions
- Artificial Intelligence and Cancer
- Cancer
- Cancer APIs and Clinical Trials
- Cancer Case Studies
- Cancer Diagnostics and Staging
- Cancer Epigenetics
- Cancer Evolution and Research
- Cancer Genomics and Epigenomics
- Cancer Treatment, Therapy and Nursing
- Chromatin Remodeling and Cancer
- Clinical Epigenetics
- Epigenetic Biomarker
- Epigenetic Therapy
- Epigenetics and Chromatin
- Histone Modifications and Cancer
Related Journals
Are you interested in
- Advancement in the Field of Cancer - CANCER THERAPY MEETING 2025 (France)
- Advancements in Early Detection and Screening - Euro Breast Cancer 2025 (France)
- Advancements in Oncology Nursing: Trends and Best Practicss - World Cancer 2025 (Switzerland)
- Advances in Breast Cancer Diagnosis - Breast Cancer Summit 2026 (France)
- Advances in Cancer Prevention and Risk Assessment - Preventive Oncology 2025 (Italy)
- Advances in Cancer Research and Treatment - Cancer Drugs 2025 (France)
- Advances in Immuno-Oncology - CANCER THERAPY MEETING 2025 (France)
- Advances in Supportive Care and Symptom Management - CANCER THERAPY MEETING 2025 (France)
- AI and Machine Learning in Cancer Care - CANCER2025 (France)
- Alternative Treatment and Cancer Therapy - Cancer Research 2025 (Spain)
- Alternative Treatments and Therapeutics - Cancer Science 2025 (France)
- Anti-Cancer Drug Discovery and Development - Cancer Research 2025 (Spain)
- Anti-Cancer Drug Discovery and Development - Cancer Drugs 2025 (France)
- Artificial Intelligence & Big Data in Breast Oncology - Breast Cancer Summit 2026 (France)
- Artificial Intelligence and Big Data in Cancer Research - CANCER THERAPY MEETING 2025 (France)
- Artificial Intelligence and Digital Health in Oncology - Euro Breast Cancer 2025 (France)
- Artificial Intelligence and Machine Learning in Oncology - Euro Cancer 2025 (France)
- Breast Cancer - Cancer Meeting Summit 2025 (France)
- Breast Cancer - Euro Cancer 2025 (France)
- Breast Cancer - Cancer Science 2025 (France)
- Breast Cancer and Pregnancy - Breast Cancer Summit 2026 (France)
- Breast Cancer Imaging and Radiology - Breast Cancer Summit 2026 (France)
- Breast Cancer in Men - Breast Cancer Summit 2026 (France)
- Breast Cancer in Young Women - Breast Cancer Summit 2026 (France)
- Breast Cancer in Young Women - Euro Breast Cancer 2025 (France)
- Breast Cancer Prevention and Lifestyle - Breast Cancer Summit 2026 (France)
- Breast Cancer Prevention and Risk Reduction - Euro Breast Cancer 2025 (France)
- Breast Cancer: Screening, Diagnosis, and Treatment - CANCER2025 (France)
- Breast Reconstruction and Cosmetic Outcomes - Breast Cancer Summit 2026 (France)
- Cancer & Stem Cell Therapy - Cancer Meeting Summit 2025 (France)
- Cancer and its Relevance with other Diseases - Cancer Drugs 2025 (France)
- Cancer Awareness and Survival - Cancer Meeting Summit 2025 (France)
- Cancer Awareness and Survival - World Cancer-2025 (Spain)
- Cancer Biology and Drug Delivery - Cancer Research 2025 (Spain)
- Cancer Biomarkers - Cancer Meeting Summit 2025 (France)
- Cancer Biomarkers & Bioinformatics - Cancer Drugs 2025 (France)
- Cancer Biopsy - Cancer Meeting Summit 2025 (France)
- Cancer Care in the Era of Digital Health - CANCER THERAPY MEETING 2025 (France)
- Cancer Case reports - Euro Cancer 2025 (France)
- Cancer Causes & Risk Factors - Cancer Drugs 2025 (France)
- Cancer Causes and Risk Factors - Cancer Meeting Summit 2025 (France)
- Cancer Cell Biology & Geneti - Cancer Meeting Summit 2025 (France)
- Cancer Cell Biology & Genetics - World Cancer-2025 (Spain)
- Cancer Clinical Trials - Cancer Research 2025 (Spain)
- Cancer Control and Prevention - Cancer Science 2025 (France)
- Cancer Diagnostics - World Cancer 2025 (Switzerland)
- Cancer Early Detection, Diagnosis and Prognosis - Cancer Meeting Summit 2025 (France)
- Cancer Epidemiology - World Cancer-2025 (Spain)
- Cancer Epidemiology - Cancer Drugs 2025 (France)
- Cancer Epidemiology and Biomarkers - Preventive Oncology 2025 (Italy)
- Cancer Epidemiology and Prevention - CANCER THERAPY MEETING 2025 (France)
- Cancer Epidemiology and Public Health - World Cancer 2025 (Switzerland)
- Cancer Epidemiology, Screening, Diagnosis & Prognosis - Cancer Research 2025 (Spain)
- Cancer Epigenetics - Cancer Science 2025 (France)
- Cancer Genetics and Epigenetics - Cancer Research 2025 (Spain)
- Cancer Genomics & Metabolomics - CANCER THERAPY MEETING 2025 (France)
- Cancer Genomics and Epigenetics - Euro Cancer 2025 (France)
- Cancer Genomics and Precision Oncology - Preventive Oncology 2025 (Italy)
- Cancer Immunology - CANCER THERAPY MEETING 2025 (France)
- Cancer Immunology & Immunotherapy - World Cancer-2025 (Spain)
- Cancer Immunology & Immunotherapy - Cancer Drugs 2025 (France)
- Cancer Immunology and Immunotherapy - World Cancer 2025 (Switzerland)
- Cancer Immunology and Immunotherapy - Preventive Oncology 2025 (Italy)
- Cancer immunotherapy: Car T Cell Technology - Cancer Research 2025 (Spain)
- Cancer Metabolism and Nutritional Interventions - CANCER2025 (France)
- Cancer Metabolism and Therapeutic Interventions - CANCER THERAPY MEETING 2025 (France)
- Cancer Metastasis - Cancer Science 2025 (France)
- Cancer Nanotechnology - World Cancer-2025 (Spain)
- Cancer Nanotechnology - Cancer Drugs 2025 (France)
- Cancer Pathology & Genetics - Cancer Drugs 2025 (France)
- Cancer Personalized Medicine - Euro Cancer 2025 (France)
- Cancer Pharma Industry - Cancer Research 2025 (Spain)
- Cancer Pharmacology - Euro Cancer 2025 (France)
- Cancer Pharmacology - World Cancer-2025 (Spain)
- Cancer Pharmacology - Cancer Drugs 2025 (France)
- Cancer Prevention & Research - Cancer Meeting Summit 2025 (France)
- Cancer Prevention and Early Detection: The Nurse’s Role - World Cancer 2025 (Switzerland)
- Cancer Prevention and Lifestyle Interventions - Euro Cancer 2025 (France)
- Cancer Prevention and Risk Reduction - CANCER2025 (France)
- Cancer Prevention Vaccines - Cancer Drugs 2025 (France)
- Cancer Preventive Vaccines: Oncolytic Therapy & Others - Cancer Research 2025 (Spain)
- Cancer Research - Euro Cancer 2025 (France)
- Cancer Science - Cancer Science 2025 (France)
- Cancer Screening & Chemotherapy - Cancer Meeting Summit 2025 (France)
- Cancer Stem Cells and Tumor Biology - CANCER2025 (France)
- Cancer Stem Cells and Tumor Heterogeneity - Euro Cancer 2025 (France)
- Cancer Stem Cells: Understanding and Targeting - CANCER THERAPY MEETING 2025 (France)
- Cancer Survivorship and Long-Term Care - Euro Cancer 2025 (France)
- Cancer Survivorship and Quality of Life - CANCER THERAPY MEETING 2025 (France)
- Cancer Therapy - Euro Cancer 2025 (France)
- Cancer Treatment and Therapeutics - World Cancer 2025 (Switzerland)
- Cancer Vaccines - Cancer Meeting Summit 2025 (France)
- Cancer Vaccines - CANCER THERAPY MEETING 2025 (France)
- Cancer Vaccines: Therapeutic and Preventive - Euro Cancer 2025 (France)
- Cancer Vaccinology and Preventive Vaccines - CANCER2025 (France)
- Cancer: Psychological & Social factors - World Cancer-2025 (Spain)
- Cancers & Stem Cell therapy - World Cancer-2025 (Spain)
- Cancers Biomarkers - Cancer Science 2025 (France)
- Cancers Biomarkers - World Cancer-2025 (Spain)
- Cancers Biopsy - World Cancer-2025 (Spain)
- Cancers Chemotherapy - World Cancer-2025 (Spain)
- Cancers Metabolomics - World Cancer-2025 (Spain)
- Cancers Metastasis - World Cancer-2025 (Spain)
- Cancers Pharmacology - Cancer Science 2025 (France)
- Cancers Prevention & Research - World Cancer-2025 (Spain)
- Cancers Therapy & Treatments - World Cancer-2025 (Spain)
- Cancers Vaccines - World Cancer-2025 (Spain)
- Cancers: lifestyle Connection and Nutrition - World Cancer-2025 (Spain)
- CAR-T Cell Therapy and Cell-Based Treatments - CANCER2025 (France)
- Cell and Gene Therapy for Cancer - Cancer Research 2025 (Spain)
- Cell and Gene Therapy for Cancer - Euro Cancer 2025 (France)
- Cell-Based Therapy - CANCER THERAPY MEETING 2025 (France)
- Circulating Tumor Cell (CTC) - Cancer Research 2025 (Spain)
- Clinical and Medical Case Reports - Cancer Drugs 2025 (France)
- Clinical Trials and New Drug Development - CANCER THERAPY MEETING 2025 (France)
- Clinical Trials and Regulatory Aspects in Oncology - CANCER2025 (France)
- Clinical Trials and Research Innovations - World Cancer 2025 (Switzerland)
- Combination Therapies and Synergistic Drug Protocols - Euro Cancer 2025 (France)
- Complementary & Alternate Methods and Cancer - World Cancer-2025 (Spain)
- CRISPR/Cas9 in CSC Research - Cancer Stem Cells 2025 (Spain)
- CSC and Immunoediting - Cancer Stem Cells 2025 (Spain)
- CSC Biomarkers for Early Detection - Cancer Stem Cells 2025 (Spain)
- CSC Fate Determination and Differentiation - Cancer Stem Cells 2025 (Spain)
- CSC Heterogeneity in Tumors - Cancer Stem Cells 2025 (Spain)
- CSC Metabolism and Energy Pathways - Cancer Stem Cells 2025 (Spain)
- CSC Niche and Hypoxia - Cancer Stem Cells 2025 (Spain)
- CSC Plasticity and Tumor Progression - Cancer Stem Cells 2025 (Spain)
- CSC-Derived Exosomes and Communication - Cancer Stem Cells 2025 (Spain)
- CSC-Driven Angiogenesis - Cancer Stem Cells 2025 (Spain)
- CSC-Driven Resistance to Radiotherapy - Cancer Stem Cells 2025 (Spain)
- CSC-Mediated Immunosuppression - Cancer Stem Cells 2025 (Spain)
- CSCs and Tumor Microenvironment - Cancer Stem Cells 2025 (Spain)
- Diagnostic Imaging in Cancer: Innovations and Future Directions - Preventive Oncology 2025 (Italy)
- DNA Damage and Mutation - Cancer Drugs 2025 (France)
- DNA Damage, Mutation and Cancer - Cancer Meeting Summit 2025 (France)
- Drug Development and Clinical Trials in Breast Cancer - Euro Breast Cancer 2025 (France)
- Drug Resistance and Overcoming Challenges - CANCER THERAPY MEETING 2025 (France)
- Drug Resistance in Cancer Therapy - Euro Cancer 2025 (France)
- Drug Resistance Mechanisms in CSCs - Cancer Stem Cells 2025 (Spain)
- Early Detection and Prevention - World Cancer 2025 (Switzerland)
- Early Detection and Screening Innovations - CANCER2025 (France)
- Emerging Technologies in Cancer Research - World Cancer 2025 (Switzerland)
- Environmental Carcinogens and Cancer Epidemiology - CANCER2025 (France)
- Epigenetics and CSC Regulation - Cancer Stem Cells 2025 (Spain)
- Ethical and Regulatory Issues in Cancer Research - CANCER THERAPY MEETING 2025 (France)
- Financial Toxicity and Healthcare Disparities in Cancer Care - Euro Cancer 2025 (France)
- Future Directions in Cancer Therapy and Research - CANCER THERAPY MEETING 2025 (France)
- Gene Editing & CRISPR in Cancer - World Cancer-2025 (Spain)
- Genetic and Environmental Factors in Cancer Development - Preventive Oncology 2025 (Italy)
- Genetic Predisposition and BRCA Mutations - Breast Cancer Summit 2026 (France)
- Genomics and Cancer Epigenetics - CANCER2025 (France)
- Global Disparities and Access to Breast Cancer Care - Euro Breast Cancer 2025 (France)
- Gynaecological Cancers - Cancer Meeting Summit 2025 (France)
- Head and Neck Cancer - Euro Cancer 2025 (France)
- Hematology- Oncology - Cancer Science 2025 (France)
- HER2-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- HER2-Positive Breast Cancer: Latest Treatment Strategies - Euro Breast Cancer 2025 (France)
- Hormone Receptor-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- Hormone Receptor-Positive Breast Cancer - Euro Breast Cancer 2025 (France)
- Immunotherapy and Cancer Vaccines - CANCER2025 (France)
- Immunotherapy and CSCs - Cancer Stem Cells 2025 (Spain)
- Immunotherapy and Emerging Targeted Therapies - Euro Breast Cancer 2025 (France)
- Immunotherapy and Immune Checkpoint Inhibitors - Euro Cancer 2025 (France)
- Inflammation and CSC Activation - Cancer Stem Cells 2025 (Spain)
- Innovations in Breast Cancer Treatment - Breast Cancer Summit 2026 (France)
- Innovations in Cancer Data and Informatics - CANCER THERAPY MEETING 2025 (France)
- Innovations in Cancer Diagnostics and Early Detection - Preventive Oncology 2025 (Italy)
- Innovative Approaches in Cancer Radiology - CANCER THERAPY MEETING 2025 (France)
- Integration of Patient-Reported Outcomes in Cancer therapy - CANCER THERAPY MEETING 2025 (France)
- Liquid Biopsies and Circulating Tumor DNA (ctDNA) - Euro Cancer 2025 (France)
- Liquid Biopsy and Early Cancer Detection - CANCER THERAPY MEETING 2025 (France)
- Liquid Biopsy and Non-Invasive Diagnostics - CANCER2025 (France)
- Managing Cancer Care & Patient Support - Cancer Drugs 2025 (France)
- Metastatic Breast Cancer: Quality of Life and Care - Euro Breast Cancer 2025 (France)
- MicroRNA and Cancer - Cancer Drugs 2025 (France)
- Molecular Biology of Cancer - World Cancer 2025 (Switzerland)
- Molecular Diagnostics and Biomarkers in Cancer - CANCER THERAPY MEETING 2025 (France)
- Molecular Oncology: From Bench to Bedside - Preventive Oncology 2025 (Italy)
- Molecular Signaling in CSCs - Cancer Stem Cells 2025 (Spain)
- Nanotechnology and CSC Targeting - Cancer Stem Cells 2025 (Spain)
- Nanotechnology in Cancer Diagnosis and Treatment - CANCER THERAPY MEETING 2025 (France)
- Nanotechnology in Cancer Treatment - Cancer Research 2025 (Spain)
- Natural Products and CSC Targeting - Cancer Stem Cells 2025 (Spain)
- Neonatal & Pediatric Oncology - Cancer Meeting Summit 2025 (France)
- Neonatal & Pediatric Oncology - World Cancer-2025 (Spain)
- Neurological Cancers & Brain Tumors - Cancer Meeting Summit 2025 (France)
- Novel Approaches to Cancer Treatment - Cancer Research 2025 (Spain)
- Novel Screening Methods for Early Detection - Preventive Oncology 2025 (Italy)
- Nursing Leadership and Professional Development in Oncology - World Cancer 2025 (Switzerland)
- Nutrition, Lifestyle, and Cancer Prevention - Preventive Oncology 2025 (Italy)
- Oncogenomics - Cancer Science 2025 (France)
- Oncology Nursing and Care - Cancer Science 2025 (France)
- Oncology Nursing and Care - World Cancer-2025 (Spain)
- Oncology Nursing and Patient Care - CANCER2025 (France)
- Oncology Nursing Care - Cancer Meeting Summit 2025 (France)
- Oncology Nursing: Advancements in Patient Care - CANCER THERAPY MEETING 2025 (France)
- Oncology Radiology, Nanotechnology - Cancer Meeting Summit 2025 (France)
- Oncolytic Virus and Cancer - Cancer Meeting Summit 2025 (France)
- Oncolytic Viruses and Novel Biologic Therapies - Euro Cancer 2025 (France)
- Organ Specific Cancer - Cancer Meeting Summit 2025 (France)
- Organ Specific Cancer - Cancer Research 2025 (Spain)
- Organ-defined Cancers - World Cancer-2025 (Spain)
- Organic Specific Cancer - Cancer Science 2025 (France)
- Palliative Care and Quality of Life - CANCER2025 (France)
- Palliative Care and Quality of Life in Cancer Patients - Euro Cancer 2025 (France)
- Pediatric and Rare Cancers - Euro Cancer 2025 (France)
- Pediatric Cancer Research and Therapeutics - CANCER THERAPY MEETING 2025 (France)
- Pediatric Oncology - World Cancer 2025 (Switzerland)
- Pediatric Oncology - Cancer Drugs 2025 (France)
- Pediatric Oncology Innovations - CANCER2025 (France)
- Personalized and Precision Oncology - Euro Cancer 2025 (France)
- Personalized Cancer Medicine and Targeted Therapy - Preventive Oncology 2025 (Italy)
- PET Scans in High-Risk Populations for Cancer Prevention - Preventive Oncology 2025 (Italy)
- Pharmacovigilance and Drug Safety in Oncology - CANCER2025 (France)
- Precision Cancers Medicinal Drug & Oncology - World Cancer-2025 (Spain)
- Precision Medicine and Genomics in Breast Cancer - Euro Breast Cancer 2025 (France)
- Precision Medicine and Immuno-Oncology - Cancer Research 2025 (Spain)
- Precision Oncology and Personalized Medicine - CANCER2025 (France)
- Preventive Oncology in Low- and Middle-Income Countries - Preventive Oncology 2025 (Italy)
- Psychosocial Oncology and Mental Health - CANCER2025 (France)
- Psychosocial Support and Survivorship - Breast Cancer Summit 2026 (France)
- Psychosocial Support and Survivorship in Breast Cancer - Euro Breast Cancer 2025 (France)
- Psychotherapy and Cancer - CANCER THERAPY MEETING 2025 (France)
- Public Health Strategies in Reducing Cancer Burden - Preventive Oncology 2025 (Italy)
- Radiation Oncology and Radiotherapy Advances - CANCER2025 (France)
- Radiation Oncology: Innovations and Techniques - CANCER THERAPY MEETING 2025 (France)
- Radiation Therapy and Technological Innovations - Euro Breast Cancer 2025 (France)
- Radiation Therapy in Breast Cancer - Breast Cancer Summit 2026 (France)
- Radiology & Imaging in Cancer Diagnosis & Therapy - Cancer Research 2025 (Spain)
- Radiology & Imaging Technologies - Cancer Drugs 2025 (France)
- Radiomics and Imaging Innovations in Cancer Detection - Euro Cancer 2025 (France)
- Rare Cancers and Orphan Drugs - CANCER2025 (France)
- Regenerative Medicines - Cancer Drugs 2025 (France)
- Robotic Oncology - Cancer Drugs 2025 (France)
- Role of AI and Machine Learning in Cancer Diagnosis - Preventive Oncology 2025 (Italy)
- Role of CSCs in Metastasis - Cancer Stem Cells 2025 (Spain)
- Role of EMT in CSC Plasticity - Cancer Stem Cells 2025 (Spain)
- Role of Microbiome in Cancer - CANCER THERAPY MEETING 2025 (France)
- Skin Cancer - Cancer Science 2025 (France)
- Supportive Care and Palliative Medicine - World Cancer 2025 (Switzerland)
- Surgical & Clinical Oncology - Cancer Drugs 2025 (France)
- Surgical Advances in Breast Cancer Management - Euro Breast Cancer 2025 (France)
- Surgical and Clinical Oncology - Cancer Meeting Summit 2025 (France)
- Surgical Oncology and Minimally Invasive Techniques - CANCER2025 (France)
- Surgical Oncology in Breast Cancer - Breast Cancer Summit 2026 (France)
- Targeted Cancer Therapy - Cancer Research 2025 (Spain)
- Targeted Therapy and Molecular Diagnostics - CANCER2025 (France)
- Targeted Therapy and Precision Medicine - CANCER THERAPY MEETING 2025 (France)
- Targeted Therapy and Small Molecule Inhibitors - Euro Cancer 2025 (France)
- Targeting CSC Dormancy - Cancer Stem Cells 2025 (Spain)
- Targeting CSC-Specific Surface Markers - Cancer Stem Cells 2025 (Spain)
- Telemedicine and Digital Health in Oncology - CANCER2025 (France)
- Therapy Resistance and CSCs - Cancer Stem Cells 2025 (Spain)
- Triple-Negative Breast Cancer (TNBC) - Breast Cancer Summit 2026 (France)
- Triple-Negative Breast Cancer: Challenges and Innovations - Euro Breast Cancer 2025 (France)
- Tumor Biology - Cancer Science 2025 (France)
- Tumor Microenvironment and Cancer Metastasis - Euro Cancer 2025 (France)
- Tumor Microenvironment and Its Role in Cancer Progression - Preventive Oncology 2025 (Italy)
- Tumor Microenvironment and Metastasis - CANCER2025 (France)
- Tumor Microenvironment and Metastasis - CANCER THERAPY MEETING 2025 (France)
- Tumor Virology - Cancer Science 2025 (France)
- Tumor Virology, Immunology & Mobile Pathology - World Cancer-2025 (Spain)
- Tumour Virology, Immunology & Cellular Pathology - Cancer Meeting Summit 2025 (France)